Enriched cancer pathway | Genes under regulation | P value |
Calcium signaling pathway |
7 genes: CHRM2, GNAL, MYLK, ATP2B4, PLCB4, PRKACB, CAMK2D
|
0.000416 |
Wnt signaling pathway |
6 genes: NFAT5, PLCB4, PPP2R5C, PRKACB, CAMK2D, CCND2
|
0.001052 |
Long.term potentiation |
4 genes: RPS6KA6, PLCB4, PRKACB, CAMK2D
|
0.001992 |
Gastric acid secretion |
4 genes: MYLK, PLCB4, PRKACB, CAMK2D
|
0.002443 |
Neurotrophin signaling pathway |
5 genes: FOXO3, RPS6KA6, NTRK3, CAMK2D, PIK3R3
|
0.00287 |
Focal adhesion |
6 genes: ARHGAP5, MYLK, PDPK1, PIK3R3, ACTN2, CCND2
|
0.004304 |
Regulation of actin cytoskeleton |
6 genes: CHRM2, ARHGEF12, MYLK, PIK3R3, ACTN2, WASL
|
0.005957 |
Jak.STAT signaling pathway |
5 genes: IL6ST, LIFR, MPL, PIK3R3, CCND2
|
0.006663 |
mTOR signaling pathway |
3 genes: RPS6KA6, PDPK1, PIK3R3
|
0.007245 |
Oocyte meiosis |
4 genes: RPS6KA6, PPP2R5C, PRKACB, CAMK2D
|
0.01122 |
Vascular smooth muscle contraction |
4 genes: ARHGEF12, MYLK, PLCB4, PRKACB
|
0.0119 |
Chemokine signaling pathway |
5 genes: FOXO3, PLCB4, PRKACB, PIK3R3, WASL
|
0.01483 |
Axon guidance |
4 genes: NFAT5, ARHGEF12, ABLIM1, PLXNA2
|
0.01742 |
Adherens junction |
3 genes: TJP1, ACTN2, WASL
|
0.01817 |
Insulin signaling pathway |
4 genes: PDPK1, PRKACB, PRKAR2A, PIK3R3
|
0.02118 |
Progesterone.mediated oocyte maturation |
3 genes: RPS6KA6, PRKACB, PIK3R3
|
0.02869 |
Hippo signaling pathway |
4 genes: YAP1, DLG2, TEAD1, CCND2
|
0.0301 |
Apoptosis |
3 genes: PRKACB, PRKAR2A, PIK3R3
|
0.0304 |
Salivary secretion |
3 genes: ATP2B4, PLCB4, PRKACB
|
0.0304 |
Cysteine and methionine metabolism |
2 genes: AHCYL2, MTR
|
0.03054 |
Gap junction |
3 genes: PLCB4, PRKACB, TJP1
|
0.03128 |
Aldosterone.regulated sodium reabsorption |
2 genes: PDPK1, PIK3R3
|
0.04052 |
GnRH signaling pathway |
3 genes: PLCB4, PRKACB, CAMK2D
|
0.04181 |
Melanogenesis |
3 genes: PLCB4, PRKACB, CAMK2D
|
0.04181 |